TEVA Teva Pharmaceutical Industries Limited Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
22:07
Jul 29
Jul 29
Long Teva, pipeline and volume growth
Teva delivered a strong Q2, raised guidance across all metrics, and sees upside in its key products. There is a large unmet patient need that will drive volume growth even as Medicare pricing rules impact pricing. The pipeline includes a Tourette's syndrome treatment with an expected approval around end of Q2 next year, and the company is well-positioned to maximize these opportunities.
LOW
About TEVA Analyst Coverage
Buzzberg tracks TEVA (Teva Pharmaceutical Industries Limited) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Latest voices: Richard Francis.